Deaddicta® for Maintenance Treatment of Opioid-dependence: A Six-month Follow-up

Overview

Journal Caspian J Intern Med

Specialty General Medicine

Date 2024 May 29

PMID 38807734

Authors

Abdolali Moosavyzadeh

Farzaneh Ghaffari

Mohammad Bagher Saberizafarghandi

Majid Talafi Noghani

Hossein Hassanpour

Fatemeh Emadi

Fatemeh Alijaniha

Zahra Bahaeddin

Leila Nasiri

Razieh Jafari Hajati

Mohsen Naseri

Affiliations

Soon will be listed here.

Abstract

Background: Opioid dependence, is one of the world's most critical health problems. Deaddicta is a herbal product considered an effective treatment for opioid addiction. Deaddicta's efficacy in the maintenance treatment of patients with opioid use disorder has recently been demonstrated through a double-blind randomized controlled trial (RCT). This study aimed to evaluate the permanence of Deaddicta's efficacy six months after the end of the maintenance treatment for opioid dependence.

Methods: This study was performed following the previous RCT on the maintenance treatment of opioid addicts. Out of 41 participants who completed the study for three months in the previous research, 15 from the intervention group (Deaddicta capsules, 1500 mg/day) returned for follow-up. They all previously fulfilled the DSM-IV criteria for addiction, were aged 18 to 65, and had discontinued Deaddicta for six months. The outcome measures included addiction severity, depression and anxiety levels, and craving score. The scores of each parameter were compared in three phases: before intervention; after three months of intervention; and six months after the end of the study.

Results: Depression, anxiety, and craving scores decreased six months after the end of the previous study. This decrease was significant in the craving score ( = 0.011). No significant increase was observed in the frequency of use. The regression analysis showed a negative relationship between craving and the progression of phases.

Conclusion: The Deaddicta product may have desirable and effective properties in decreasing temptation and, as a result, the maintenance treatment of opioid dependence.

References

Noller G, Frampton C, Yazar-Klosinski B . Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. Am J Drug Alcohol Abuse. 2017; 44(1):37-46. DOI: 10.1080/00952990.2017.1310218. View

Abbaszadeh-Mashkani S, Hoque S, Banafshe H, Ghaderi A . The effect of crocin (the main active saffron constituent) on the cognitive functions, craving, and withdrawal syndrome in opioid patients under methadone maintenance treatment. Phytother Res. 2020; 35(3):1486-1494. DOI: 10.1002/ptr.6913. View

Moosavyzadeh A, Mokri A, Ghaffari F, Faghihzadeh S, Azizi H, Jafari Hajati R . Hab-o Shefa, a Persian Medicine Compound for Maintenance Treatment of Opioid Dependence: Randomized Placebo-Controlled Clinical Trial. J Altern Complement Med. 2020; 26(5):376-383. DOI: 10.1089/acm.2019.0390. View

Naseri V, Chavoshzadeh Z, Mizani A, Daneshfard B, Ghaffari F, Abbas-Mohammadi M . Effect of topical marshmallow (Althaea officinalis) on atopic dermatitis in children: A pilot double-blind active-controlled clinical trial of an in-silico-analyzed phytomedicine. Phytother Res. 2020; 35(3):1389-1398. DOI: 10.1002/ptr.6899. View

Cirillo C, Capasso R . Constipation and Botanical Medicines: An Overview. Phytother Res. 2015; 29(10):1488-93. DOI: 10.1002/ptr.5410. View

Tu Y, Cheng S, Sun H, Ma T, Zhang S . Ferulic acid potentiates pentobarbital-induced sleep via the serotonergic system. Neurosci Lett. 2012; 525(2):95-9. DOI: 10.1016/j.neulet.2012.07.068. View

Le T, Le M, Dang A, Dang A, Nguyen C, Pham H . Multi-level predictors of psychological problems among methadone maintenance treatment patients in difference types of settings in Vietnam. Subst Abuse Treat Prev Policy. 2019; 14(1):39. PMC: 6751619. DOI: 10.1186/s13011-019-0223-4. View

Liu Y, Yan F, Liu Y, Zhang C, Yu H, Zhang Y . Aqueous extract of rhubarb stabilizes vulnerable atherosclerotic plaques due to depression of inflammation and lipid accumulation. Phytother Res. 2008; 22(7):935-42. DOI: 10.1002/ptr.2429. View

Saberi Zafarghandi M, Jadidi M, Khalili N . Iran's Activities on Prevention, Treatment and Harm Reduction of Drug Abuse. Int J High Risk Behav Addict. 2016; 4(4):e22863. PMC: 4744908. DOI: 10.5812/ijhrba.22863. View

10.

Soni P, Siddiqui A, Dwivedi J, Soni V . Pharmacological properties of Datura stramonium L. as a potential medicinal tree: an overview. Asian Pac J Trop Biomed. 2013; 2(12):1002-8. PMC: 3621465. DOI: 10.1016/S2221-1691(13)60014-3. View

11.

Ademiluyi A, Ogunsuyi O, Oboh G . Alkaloid extracts from Jimson weed (Datura stramonium L.) modulate purinergic enzymes in rat brain. Neurotoxicology. 2016; 56:107-117. DOI: 10.1016/j.neuro.2016.06.012. View

12.

Maier W, Buller R, Philipp M, Heuser I . The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988; 14(1):61-8. DOI: 10.1016/0165-0327(88)90072-9. View

13.

Mohammed Nawi A, Ismail R, Ibrahim F, Hassan M, Abdul Manaf M, Amit N . Risk and protective factors of drug abuse among adolescents: a systematic review. BMC Public Health. 2021; 21(1):2088. PMC: 8590764. DOI: 10.1186/s12889-021-11906-2. View

14.

Kakko J, Alho H, Baldacchino A, Molina R, Nava F, Shaya G . Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice. Front Psychiatry. 2019; 10:592. PMC: 6728888. DOI: 10.3389/fpsyt.2019.00592. View

15.

Berrios-Carcamo P, Quezada M, Quintanilla M, Morales P, Ezquer M, Herrera-Marschitz M . Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules. Antioxidants (Basel). 2020; 9(9). PMC: 7555323. DOI: 10.3390/antiox9090830. View

16.

Li M, Fu Q, Li Y, Li S, Xue J, Ma S . Emodin opposes chronic unpredictable mild stress induced depressive-like behavior in mice by upregulating the levels of hippocampal glucocorticoid receptor and brain-derived neurotrophic factor. Fitoterapia. 2014; 98:1-10. DOI: 10.1016/j.fitote.2014.06.007. View

17.

Liang T, Liu E, Zhong H, Wang B, Shen L, Wu Z . Reliability and validity of addiction severity index in drug users with methadone maintenance treatment in Guizhou province, China. Biomed Environ Sci. 2008; 21(4):308-13. DOI: 10.1016/S0895-3988(08)60047-1. View

18.

DOnofrio G, Chawarski M, OConnor P, Pantalon M, Busch S, Owens P . Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention. J Gen Intern Med. 2017; 32(6):660-666. PMC: 5442013. DOI: 10.1007/s11606-017-3993-2. View

19.

Sadeghi S, Ghaffari F, Heydarirad G, Alizadeh M . Galen's place in Avicenna's The Canon of Medicine: Respect, confirmation and criticism. J Integr Med. 2019; 18(1):21-25. DOI: 10.1016/j.joim.2019.11.002. View

20.

Jakabova S, Vincze L, Farkas A, Kilar F, Boros B, Felinger A . Determination of tropane alkaloids atropine and scopolamine by liquid chromatography-mass spectrometry in plant organs of Datura species. J Chromatogr A. 2012; 1232:295-301. DOI: 10.1016/j.chroma.2012.02.036. View